Drug name - Latisse

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8038988 ALLERGAN Method of enhancing hair growth
Aug, 2023

(10 months from now)

EP2802331A1 ALLERGAN Topical Treatment For Chemotherapy Induced Eyelash Loss Or Hypotrichosis Using Prostamide F2 Alpha Agonists
Jan, 2033

(10 years from now)

EP2802331B1 ALLERGAN Topical Treatment For Chemotherapy Induced Eyelash Loss Or Hypotrichosis Using Prostamide F2 Alpha Agonists
Jan, 2033

(10 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8986715 ALLERGAN Method of enhancing hair growth Jan, 2023

(3 months from now)

US9226931 ALLERGAN Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists Jan, 2023

(3 months from now)

US8632760 ALLERGAN Method of enhancing hair growth Jan, 2023

(3 months from now)

US8263054 ALLERGAN Method of enhancing hair growth Jan, 2023

(3 months from now)

US9216183 ALLERGAN Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists Jan, 2023

(3 months from now)

US8758733 ALLERGAN Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists Jan, 2023

(3 months from now)

US8101161 ALLERGAN Method of enhancing hair growth May, 2024

(1 year, 7 months from now)

Drugs and Companies using BIMATOPROST ingredient

Treatment: Method of increasing hair growth; Method of increasing growth of hair including eyelashes; Method of increasing eyelash growth; Method of increasing eyelash growth including length, thickness, darkness and/or number of eyelashes by administering bimatoprost to an eyelid margin; Method of stimulating hair growth; method of increasing hair growth

Dosage: SOLUTION/DROPS;TOPICAL

More Information on Dosage
Strength Dosage Availability
0.03% SOLUTION/DROPS;TOPICAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.